In “The Cost of Capture: How the Pharmaceutical Industry Has Corrupted Policymakers and Harmed Patients,” Roosevelt Fellow Julie Margetta Morgan and Advocacy Associate Devin Duffy explore how drug companies influence policymakers and what this means for patients, the American health care system, and our economy. One of a series on Big Pharma, this issue brief

Each Saturday, a Roosevelt staff member will share 3-5 articles that they consider must-reads. This week, Roosevelt Communications Director Kendra Bozarth is sharing an antitrust reading list and elevates the hidden rules of drug addiction. I recently finished Good and Mad by Rebecca Traister, which is fitting because I am definitely a woman signaling fury

FOR IMMEDIATE RELEASE: April 10, 2019 CONTACT: Ariela Weinberger, aweinberger@rooseveltinstitute.org A New 21st Century Policy Agenda: Roosevelt Report Proposes Changing the Balance of Power in the Economy At Washington DC launch event, Roosevelt experts presented a new approach to policymaking, with a keynote from former Georgia House Minority Leader Stacey Abrams WASHINGTON, DC — Today,

FOR IMMEDIATE RELEASE: April 10, 2019 CONTACT: Ariela Weinberger, aweinberger@rooseveltinstitute.org Roosevelt Institute Releases New Policy Report on Tackling 21st Century Economic Challenges New report offers bold approach to policymaking: curbing concentrated power and reclaiming public power in our economy and political system NEW YORK, NY — Today, the Roosevelt Institute, a New York-based think tank

America’s political landscape and economic thinking are shifting. The 2016 election—and the rise of powerful movements over the past decade—has shown us that Americans are calling for change. They want a diagnosis of our economy to help make sense of what’s gone wrong and to suggest ways to make things better. In New Rules for

The pharmaceutical industry isn’t working for most people in the US. Over 80 percent of Americans across the political spectrum believe that lowering drug costs should be a “top priority” for lawmakers and believe that prescription drug costs are “unreasonable.” This growing scrutiny presents an opportunity to question the ways that drug corporations run business, as

FOR IMMEDIATE RELEASE: February 21, 2019 CONTACT: Ariela Weinberger, aweinberger@rooseveltinstitute.org Kathy Mulady, k.mulady@peoplesaction.org   Creation of a Crisis: Why the Pharmaceutical Industry Chooses Profit Over People New issue brief explores how US policy choices have led to high drug prices, low health care investment, misaligned incentives, and escalating CEO pay across the pharmaceutical industry  

Recently, The New York Times published a report about women who, while working in physically demanding jobs, lost their pregnancies after requests for less-strenuous assignments were denied. The profile is a tragic example of the steep toll levied on women, and particularly women of color, who face economic and social rules that are rigged against

The George Washington University (GW) has a student health insurance problem. Annual insurance premiums for the university-sponsored student health insurance plan (SHIP) reached a five-year high of $4,103 for the 2017-18 policy year. This cost is exorbitantly high in comparison to similar plans offered by many other universities, discouraging students from enrolling in the school’s

Last week, Donald Trump’s chief of staff John Kelly lamented that the world has changed for women. “When I was a kid growing up, a lot of things were sacred in our country,” he said. “Women were sacred and looked upon with great honor. That’s obviously not the case anymore, as we see from recent

Tagged under: , ,